DaVita Inc (NYSE:DVA) - Share price


Stock Report

DaVita Inc DVA

Last Price
$121.26

Day Change
-0.67|-0.55%

As of 16/09/2021
16:14:17 EDT | USD
Minimum 15 Minutes Delay.

Last Close121.93
Day Range120.80 - 123.09
Mkt Cap12.70Bil
52-Wk Range80.85 - 136.48
Yield %-
ISINUS23918K1088
Volume784,499
P/E15.90
P/S1.22
P/CF7.82

Share Price

Financials
201820192020
More ...
Income Statement
Revenue11,404.8511,388.4811,550.60
Operating Income1,490.151,755.531,683.97
Net Income159.39810.98773.64
Basic EPS0.935.296.46
Avg. Diluted Shares Outstanding172154123
Balance Sheet
Current Assets8,424.163,690.173,148.72
Non Current Assets10,686.0913,621.2213,839.79
Total Assets19,110.2517,311.3916,988.52
Current Liabilities4,891.162,372.102,476.14
Total Liabilities15,201.8514,992.1515,421.76
Total Equity3,703.442,133.411,383.57
Cash Flow
Operating Cash Flow1,771.642,072.361,979.03
Capital Expenditure-987.14-766.55-674.54
Free Cash Flow784.501,305.811,304.49

In millions, except "Basic EPS". Currency is USD.

Company Profile

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government ( primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Sector

Healthcare

Industry

Medical Care Facilities

Stock Style

Mid-Blend

Fiscal Year Ends

December

Employees

67,000
Key Stats
More ...
Price/Earning TTM15.57
Price/Book9.99
Price/Sales TTM1.26
Rev Growth (3 year avg)2.02
EPS Growth (3 year avg)-
Operating Margin % TTM14.58
Net Margin % TTM6.70
ROE TTM43.99
Debt/Equity7.70
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.